Furthermore, the STAT3 inhibitor WP1066 has been shown to downregulate SMYD3 transcription by inhibiting the binding of STAT3 to the SMYD3 promoter, suppressing chronic lymphocytic leukemia cell growth in vivo99. The gene discussed is STAT3; the disease is B-cell chronic lymphocytic leukemia.